You are herePharma News

Pharma News


Cone Snail Venom may Hold Cure for Cancer, Addiction

Cone snail venom may lead to medical treatments for some cancers and nicotine addiction, a new study has found. Cone snails are marine mollusks, just as conch, octopi and squid, but they capture their prey using venom. The venom of these marine critters provides leads for detection and possible treatment of some cancers and addictions, researchers said.


Ebola virus could be infectious even after death of victim

To determine how long Ebola virus could remain infectious in a body after death, National Institutes of Health (NIH) scientists sampled deceased Ebola-infected monkeys and discovered the virus remained viable for at least seven days.


GSK acquire vaccine biopharmaceutical company-GlycoVaxyn AG

GSK has acquired GlycoVaxyn AG, a specialist vaccine biopharmaceutical company based in Switzerland and seems to stregthen their vaccine pipeline. Since forming a scientific collaboration in 2012, GSK has held a minority stake in GlycoVaxyn and has now acquired the remaining shares for US $190 million (approximately £124 million) in cash to take full ownership of the company.


3-D Facial imaging may help detect autism early

Advanced 3-D facial imaging may aid in early detection of autism in kids, say scientists. Researchers at the University of Missouri used advanced three-dimensional imaging and statistical analysis techniques to identify facial measurements in children with autism that may lead to a screening tool for young children and provide clues to its genetic causes.


20-Minute daily walk may cut risk of early death

A brisk 20-minute walk each day could be enough to reduce an individual’s risk of early death, according to a new research. The study of European men and women found that twice as many deaths may be attributable to lack of physical activity compared with the number of deaths attributable to obesity.


DNA 'Smart Glue' may help build Tissues, Organs

DNA strands can act as a glue to hold together 3-D-printed materials that could someday be used to grow tissues and organs in the lab, a new study has found. Researchers from the University of Texas at Austin said that although scientists have used nucleic acids such as DNA to assemble objects, most of these are nanosized - so tiny that humans can’t see them with the naked eye.


Industry Interaction Meet “Development & Commercialization of Biotechnology based Antibodies: Collaboration Opportunity with CCAB, Canada”

CII-Centre of Excellence in Nanotechnology(CoE-NT), Gujarat Knowledge Application Facilitation Centre (GKAFC), Intellectual Property Facilitation Centre (IPFC) & Canada India Business Exchange(CIBX) jointly organized Industry interaction meet for Center for Commercialization of Antibodies and Biologics(CCAB), Canada on 11 February 2015, Hotel Novotel, S.G. Highway, Ahmedabad. CCAB has already developed hundreds of human antibodies that are potential therapeutic candidates for the treatment of cancer, AMD and other Infectious and Metabolic diseases.


Trying to quit smoking? Avoid pretty women

Men are less likely to quit smoking when looking at attractive women, according to a new study which asked men to rate how appealing pictures of different women were. In an experiment, scientists from Taiwan asked 76 men to rate pictures of various women.


Napping Boosts Memory Development in Babies

Parents, take note! Daytime naps of 30 minutes or more help babies retain and remember new behaviours, a first of its kind study has found. Researchers from the University of Sheffield, UK, and Ruhr University Bochum, Germany explored whether daytime sleep after learning helped babies to remember new behaviour.


First Contracting Human Muscle Grown in Lab

Researchers have for the first time grown human skeletal muscle in the lab which contracts and responds just like native tissue to external stimuli such as electrical pulses, biochemical signals and pharmaceuticals. The lab-grown tissue will allow researchers to test new drugs and study diseases in functioning human muscle outside of the human body to provide personalised medicine to patients.